Trial Profile
The add-on effect of Tiotropium bromide to ICS/LABA combination inhaler for the patients with severe uncontrolled asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2019
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 12 Sep 2019 Status changed from active, no longer recruiting to completed.
- 03 Dec 2015 New trial record